Samuel Tekeste Workenhe (Samuel T Workenhe)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Journal for immunotherapy of cancer

Communications biology

Oncoimmunology

PLoS pathogens

This page only lists publications with an associated author ORCID identifier.

Publications

Jordon M Inkol, Michael J Westerveld, Shayla G Verburg, Scott R Walsh, Jodi Morrison, Karen L Mossman, Sarah M Worfolk, Kaslyn Lf Kallio, Noah J Phippen, Rebecca Burchett, Yonghong Wan, Jonathan L Bramson, Samuel Tekeste Workenhe
Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells. Journal for immunotherapy of cancer 12 (4) (2024)
Jordon M Inkol, Michael J Westerveld, Shayla G Verburg, Scott R Walsh, Jodi Morrison, Karen L Mossman, Sarah M Worfolk, Kaslyn Lf Kallio, Noah J Phippen, Rebecca Burchett, Yonghong Wan, Jonathan L Bramson, Samuel Tekeste Workenhe
Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells. Journal for immunotherapy of cancer 12 (4) (2024)
Jordon M Inkol, Michael J Westerveld, Shayla G Verburg, Scott R Walsh, Jodi Morrison, Karen L Mossman, Sarah M Worfolk, Kaslyn Lf Kallio, Noah J Phippen, Rebecca Burchett, Yonghong Wan, Jonathan L Bramson, Samuel Tekeste Workenhe
Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells. Journal for immunotherapy of cancer 12 (4) (2024)
Jordon M Inkol, Michael J Westerveld, Shayla G Verburg, Scott R Walsh, Jodi Morrison, Karen L Mossman, Sarah M Worfolk, Kaslyn Lf Kallio, Noah J Phippen, Rebecca Burchett, Yonghong Wan, Jonathan L Bramson, Samuel Tekeste Workenhe
Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells. Journal for immunotherapy of cancer 12 (4) (2024)
Huy-Dung Hoang, Aida Said, Nasana Vaidya, Victoria H Gilchrist, Kyle Malone, Usha Kabilan, Serena Topshee, Xiao Xiang, An-Dao Yang, David Olagnier, Karen Mossman, Shawn T Beug, Seyed Mehdi Jafarnejad, Samuel Tekeste Workenhe, Tyson E Graber, Tommy Alain
Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1. Journal for immunotherapy of cancer 11 (3) (2023)
Huy-Dung Hoang, Aida Said, Nasana Vaidya, Victoria H Gilchrist, Kyle Malone, Usha Kabilan, Serena Topshee, Xiao Xiang, An-Dao Yang, David Olagnier, Karen Mossman, Shawn T Beug, Seyed Mehdi Jafarnejad, Samuel Tekeste Workenhe, Tyson E Graber, Tommy Alain
Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1. Journal for immunotherapy of cancer 11 (3) (2023)
Huy-Dung Hoang, Aida Said, Nasana Vaidya, Victoria H Gilchrist, Kyle Malone, Usha Kabilan, Serena Topshee, Xiao Xiang, An-Dao Yang, David Olagnier, Karen Mossman, Shawn T Beug, Seyed Mehdi Jafarnejad, Samuel Tekeste Workenhe, Tyson E Graber, Tommy Alain
Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1. Journal for immunotherapy of cancer 11 (3) (2023)
Samuel Tekeste Workenhe, Jordon M Inkol, Michael J Westerveld, Shayla G Verburg, Sarah M Worfolk, Scott R Walsh, Kaslyn L F Kallio
Determinants for Antitumor and Protumor Effects of Programmed Cell Death. Cancer immunology research (2023)
Shayla Grace Verburg, Rebecca Margaret Lelievre, Michael James Westerveld, Jordon Marcus Inkol, Yi Lin Sun, Samuel Tekeste Workenhe
Viral-mediated activation and inhibition of programmed cell death. PLoS pathogens 18 (8) (2022)
Samuel Tekeste Workenhe, Jonathan Pol, Guido Kroemer
Tumor-intrinsic determinants of immunogenic cell death modalities. Oncoimmunology 10 (1) (2021)
Alyssa Vito, Omar Salem, Nader El-Sayes, Ian P MacFawn, Ana L Portillo, Katy Milne, Danielle Harrington, Ali A Ashkar, Yonghong Wan, Samuel Tekeste Workenhe, Brad H Nelson, Tullia C Bruno, Karen Louise Mossman
Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells. Communications biology 4 (1) (2021)
Samuel Tekeste Workenhe, Andrew Nguyen, David Bakhshinyan, Jiarun Wei, David N Hare, Kelly L MacNeill, Yonghong Wan, Andrew Oberst, Jonathan L Bramson, Jalees A Nasir, Alyssa Vito, Nader El-Sayes, Sheila K Singh, Andrew G McArthur, Karen Louise Mossman
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors. Communications biology 3 (1) (2020)
Jacob P van Vloten, Samuel Tekeste Workenhe, Sarah K Wootton, Karen L Mossman, Byram W Bridle
Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies. Journal of immunology (Baltimore, Md. : 1950) 200 (2) (2018)

Samuel Tekeste Workenhe.css-eqlu8i{font-size:small;padding-left:4px;} (Samuel T Workenhe)

Publication Activity (10 Years)

Top Topics

Top Venues

Samuel Tekeste Workenhe (Samuel T Workenhe)